Global Nuclease Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Nuclease Market
A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.

Due to the COVID-19 pandemic, the global Nuclease market size is estimated to be worth US$ 532.9 million in 2022 and is forecast to a readjusted size of US$ 817.9 million by 2028 with a CAGR of 7.4% during the review period. Fully considering the economic change by this health crisis, DNases accounting for % of the Nuclease global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Academic & Research Institutes segment is altered to an % CAGR throughout this forecast period.

The global well-known brands in Nuclease include New England Biolabs(14.61%), MercK(7.28%), Illumina(6.73%), Thermo Fisher Scientific(4.51%), Agilent Technologies(3.84%), Cytiva(2.99%), Roche(2.94%), Takara Bio(2.47%), C-LEcta(1.90%), Aldevron(1.72%), Lucigen(1.39%), Promega Corporation(1.26%), Qiagen(1.01%), Amicogen(0.60%), Codexis(0.51%), BBI Solution(0.31%) and Others(45.95%).

The application area of Nuclease includes Academic & Research Institutes, Biopharmaceutical, Hospitals & Diagnostic Centers and Other.

In terms of types, Nuclease can be divided into DNases and RNases.

On basis of geography, Nuclease is manufactured in North America, Europe, Japan and Korea.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

DNases

RNases

Segment by Application

Academic & Research Institutes

Biopharmaceutical

Hospitals & Diagnostic Centers

Other

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Nuclease market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

New England Biolabs

MercK

Illumina

Thermo Fisher Scientific

Agilent Technologies

Cytiva

Roche

Takara Bio

C-LEcta

Aldevron

Lucigen

Promega Corporation

Qiagen

Amicogen

Codexis

BBI Solution

TABLE OF CONTENT

1 Study Coverage
1.1 Nuclease Product Introduction

1.2 Market by Type

1.2.1 Global Nuclease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 DNases

1.2.3 RNases

1.3 Market by Application

1.3.1 Global Nuclease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Academic & Research Institutes

1.3.3 Biopharmaceutical

1.3.4 Hospitals & Diagnostic Centers

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Nuclease Sales Estimates and Forecasts 2017-2028

2.2 Global Nuclease Revenue Estimates and Forecasts 2017-2028

2.3 Global Nuclease Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Nuclease Sales by Region

2.4.1 Global Nuclease Sales by Region (2017-2022)

2.4.2 Global Sales Nuclease by Region (2023-2028)

2.5 Global Nuclease Revenue by Region

2.5.1 Global Nuclease Revenue by Region (2017-2022)

2.5.2 Global Nuclease Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Nuclease Sales by Manufacturers

3.1.1 Global Top Nuclease Manufacturers by Sales (2017-2022)

3.1.2 Global Nuclease Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclease in 2021

3.2 Global Nuclease Revenue by Manufacturers

3.2.1 Global Nuclease Revenue by Manufacturers (2017-2022)

3.2.2 Global Nuclease Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Nuclease Revenue in 2021

3.3 Global Nuclease Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Nuclease Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Nuclease Sales by Type

4.1.1 Global Nuclease Historical Sales by Type (2017-2022)

4.1.2 Global Nuclease Forecasted Sales by Type (2023-2028)

4.1.3 Global Nuclease Sales Market Share by Type (2017-2028)

4.2 Global Nuclease Revenue by Type

4.2.1 Global Nuclease Historical Revenue by Type (2017-2022)

4.2.2 Global Nuclease Forecasted Revenue by Type (2023-2028)

4.2.3 Global Nuclease Revenue Market Share by Type (2017-2028)

4.3 Global Nuclease Price by Type

4.3.1 Global Nuclease Price by Type (2017-2022)

4.3.2 Global Nuclease Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Nuclease Sales by Application

5.1.1 Global Nuclease Historical Sales by Application (2017-2022)

5.1.2 Global Nuclease Forecasted Sales by Application (2023-2028)

5.1.3 Global Nuclease Sales Market Share by Application (2017-2028)

5.2 Global Nuclease Revenue by Application

5.2.1 Global Nuclease Historical Revenue by Application (2017-2022)

5.2.2 Global Nuclease Forecasted Revenue by Application (2023-2028)

5.2.3 Global Nuclease Revenue Market Share by Application (2017-2028)

5.3 Global Nuclease Price by Application

5.3.1 Global Nuclease Price by Application (2017-2022)

5.3.2 Global Nuclease Price Forecast by Application (2023-2028)

6 North America

6.1 North America Nuclease Market Size by Type

6.1.1 North America Nuclease Sales by Type (2017-2028)

6.1.2 North America Nuclease Revenue by Type (2017-2028)

6.2 North America Nuclease Market Size by Application

6.2.1 North America Nuclease Sales by Application (2017-2028)

6.2.2 North America Nuclease Revenue by Application (2017-2028)

6.3 North America Nuclease Market Size by Country

6.3.1 North America Nuclease Sales by Country (2017-2028)

6.3.2 North America Nuclease Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Nuclease Market Size by Type

7.1.1 Europe Nuclease Sales by Type (2017-2028)

7.1.2 Europe Nuclease Revenue by Type (2017-2028)

7.2 Europe Nuclease Market Size by Application

7.2.1 Europe Nuclease Sales by Application (2017-2028)

7.2.2 Europe Nuclease Revenue by Application (2017-2028)

7.3 Europe Nuclease Market Size by Country

7.3.1 Europe Nuclease Sales by Country (2017-2028)

7.3.2 Europe Nuclease Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Nuclease Market Size by Type

8.1.1 Asia Pacific Nuclease Sales by Type (2017-2028)

8.1.2 Asia Pacific Nuclease Revenue by Type (2017-2028)

8.2 Asia Pacific Nuclease Market Size by Application

8.2.1 Asia Pacific Nuclease Sales by Application (2017-2028)

8.2.2 Asia Pacific Nuclease Revenue by Application (2017-2028)

8.3 Asia Pacific Nuclease Market Size by Region

8.3.1 Asia Pacific Nuclease Sales by Region (2017-2028)

8.3.2 Asia Pacific Nuclease Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Nuclease Market Size by Type

9.1.1 Latin America Nuclease Sales by Type (2017-2028)

9.1.2 Latin America Nuclease Revenue by Type (2017-2028)

9.2 Latin America Nuclease Market Size by Application

9.2.1 Latin America Nuclease Sales by Application (2017-2028)

9.2.2 Latin America Nuclease Revenue by Application (2017-2028)

9.3 Latin America Nuclease Market Size by Country

9.3.1 Latin America Nuclease Sales by Country (2017-2028)

9.3.2 Latin America Nuclease Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Nuclease Market Size by Type

10.1.1 Middle East and Africa Nuclease Sales by Type (2017-2028)

10.1.2 Middle East and Africa Nuclease Revenue by Type (2017-2028)

10.2 Middle East and Africa Nuclease Market Size by Application

10.2.1 Middle East and Africa Nuclease Sales by Application (2017-2028)

10.2.2 Middle East and Africa Nuclease Revenue by Application (2017-2028)

10.3 Middle East and Africa Nuclease Market Size by Country

10.3.1 Middle East and Africa Nuclease Sales by Country (2017-2028)

10.3.2 Middle East and Africa Nuclease Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 New England Biolabs

11.1.1 New England Biolabs Corporation Information

11.1.2 New England Biolabs Overview

11.1.3 New England Biolabs Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 New England Biolabs Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 New England Biolabs Recent Developments

11.2 MercK

11.2.1 MercK Corporation Information

11.2.2 MercK Overview

11.2.3 MercK Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 MercK Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 MercK Recent Developments

11.3 Illumina

11.3.1 Illumina Corporation Information

11.3.2 Illumina Overview

11.3.3 Illumina Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Illumina Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Illumina Recent Developments

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Corporation Information

11.4.2 Thermo Fisher Scientific Overview

11.4.3 Thermo Fisher Scientific Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Thermo Fisher Scientific Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Thermo Fisher Scientific Recent Developments

11.5 Agilent Technologies

11.5.1 Agilent Technologies Corporation Information

11.5.2 Agilent Technologies Overview

11.5.3 Agilent Technologies Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Agilent Technologies Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Agilent Technologies Recent Developments

11.6 Cytiva

11.6.1 Cytiva Corporation Information

11.6.2 Cytiva Overview

11.6.3 Cytiva Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Cytiva Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Cytiva Recent Developments

11.7 Roche

11.7.1 Roche Corporation Information

11.7.2 Roche Overview

11.7.3 Roche Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Roche Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Roche Recent Developments

11.8 Takara Bio

11.8.1 Takara Bio Corporation Information

11.8.2 Takara Bio Overview

11.8.3 Takara Bio Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Takara Bio Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Takara Bio Recent Developments

11.9 C-LEcta

11.9.1 C-LEcta Corporation Information

11.9.2 C-LEcta Overview

11.9.3 C-LEcta Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 C-LEcta Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 C-LEcta Recent Developments

11.10 Aldevron

11.10.1 Aldevron Corporation Information

11.10.2 Aldevron Overview

11.10.3 Aldevron Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Aldevron Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Aldevron Recent Developments

11.11 Lucigen

11.11.1 Lucigen Corporation Information

11.11.2 Lucigen Overview

11.11.3 Lucigen Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Lucigen Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Lucigen Recent Developments

11.12 Promega Corporation

11.12.1 Promega Corporation Corporation Information

11.12.2 Promega Corporation Overview

11.12.3 Promega Corporation Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Promega Corporation Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Promega Corporation Recent Developments

11.13 Qiagen

11.13.1 Qiagen Corporation Information

11.13.2 Qiagen Overview

11.13.3 Qiagen Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.13.4 Qiagen Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Qiagen Recent Developments

11.14 Amicogen

11.14.1 Amicogen Corporation Information

11.14.2 Amicogen Overview

11.14.3 Amicogen Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.14.4 Amicogen Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Amicogen Recent Developments

11.15 Codexis

11.15.1 Codexis Corporation Information

11.15.2 Codexis Overview

11.15.3 Codexis Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.15.4 Codexis Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Codexis Recent Developments

11.16 BBI Solution

11.16.1 BBI Solution Corporation Information

11.16.2 BBI Solution Overview

11.16.3 BBI Solution Nuclease Sales, Price, Revenue and Gross Margin (2017-2022)

11.16.4 BBI Solution Nuclease Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 BBI Solution Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Nuclease Industry Chain Analysis

12.2 Nuclease Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Nuclease Production Mode & Process

12.4 Nuclease Sales and Marketing

12.4.1 Nuclease Sales Channels

12.4.2 Nuclease Distributors

12.5 Nuclease Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Nuclease Industry Trends

13.2 Nuclease Market Drivers

13.3 Nuclease Market Challenges

13.4 Nuclease Market Restraints

14 Key Findings in The Global Nuclease Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample